Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Director dealing & loan note

7th Dec 2007 07:01

International Medical Devices PLC07 December 2007 7 December 2007 International Medical Devices plc ("IMD" or "the Company") Directors Remuneration and Convertible Loan Note International Medical Devices plc (AIM: INT), the medical supply companytargeting the acute care, aged care, and devices markets, announces that its newCEO has agreed to take part of his remuneration in shares above the currentmarket price, and that it has signed a convertible loan note. Bill McGrath joined the company as Chief Operating Officer on 2 November 2007,and became the Company's Chief Executive Officer on 3 December 2007. He hasagreed to convert, in aggregate £70,000 of his remuneration into OrdinaryShares, at a price higher than today's market price, being 1,125,000 OrdinaryShares at 4p and 500,000 Ordinary Shares at 5p, being a total of 1,625,000Ordinary Shares. The Company has also entered into a two year loan note with Trafalgar CapitalSpecialized Investment Fund amounting to £600,000 which carries conversionrights into Ordinary shares. IMD intends to utilise the funds in support of theCompany's "buy and build" strategy, relating to potential acquisitionopportunities. The provider has been issued 329,272 Ordinary Shares on enteringinto the agreement. Application has been made for the above 1,954,272 Ordinary Shares to be admittedto trading on AIM. It is expected that admission to trading on AIM will beeffected and dealings in these new Ordinary Shares will commence on 13 December2007. Lindsay Sanford, Executive Chairman, said: "Bill's offer to take part payment in shares above current market price is asignificant vote of confidence in the strength of the Company and its plans forthe future. We look forward to working with him in his new role as CEO, toimplement a robust business plan to enhance our existing businesses and enableus to make further acquisitions. The convertible loan note will help expedite these acquisitions, by giving usflexible cash flow to cover costs relating to the acquisition of new businessesto add to our growing portfolio." For further information, contact: International Medical Devices JM Finn Parkgreen Communications Mike Acheson, FD Geoff Nash Simon Robinson / Erica Nelson +44 20 3008 4960 +44 20 7600 1658 +44 20 7851 7480 This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Intelliam Ai
FTSE 100 Latest
Value10,416.62
Change-36.06